Clinical trial
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis: An Open-label, Multicenter, Randomized, Controlled Trial: NoVa
NCT06464510 is registered in ClinicalTrials.gov with Hospital do Coracao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis: An Open-label, Multicenter, Randomized, Controlled Trial: NoVa
- Lead sponsor
- Hospital do Coracao
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- November 21, 2024
- Completion date
- September 30, 2027
- Enrollment
- 2,800 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock